Earnings Feed
Start Free
Home/Filings/4/A/0000950159-06-000002
4/A//SEC Filing

BLUMBERG CAPITAL MANAGEMENT LLC 4/A

Accession 0000950159-06-000002

CIK 0000913443other
View on SEC.govCompany Profile

Filed

Jan 2, 7:00 PM ET

Accepted

Jan 3, 5:13 PM ET

Size

18.5 KB

Accession

0000950159-06-000002

Insider Transaction Report

Form 4/AAmended
Period: 2005-12-27
CAMBRIDGE HEART INCCAMH.OB
AFB FUND LLC
10% Owner
Transactions
  • Purchase

    Common Stock

    2005-12-27$0.75/sh+18,000$13,500→ 1,782,672 total(indirect: See footnotes)
Holdings

  • Common Stock

    (indirect: See footnotes)
    63,180

  • Common Stock

    (indirect: See footnotes)
    316,500

  • Common Stock

    (indirect: See footnotes)
    466,128
BLUMBERG CAPITAL MANAGEMENT LLC
10% Owner
Transactions
  • Purchase

    Common Stock

    2005-12-27$0.75/sh+18,000$13,500→ 1,782,672 total(indirect: See footnotes)
Holdings

  • Common Stock

    (indirect: See footnotes)
    63,180

  • Common Stock

    (indirect: See footnotes)
    466,128

  • Common Stock

    (indirect: See footnotes)
    316,500
BLUMBERG LIFE SCIENCES FUND LP
10% Owner
Transactions
  • Purchase

    Common Stock

    2005-12-27$0.75/sh+18,000$13,500→ 1,782,672 total(indirect: See footnotes)
Holdings

  • Common Stock

    (indirect: See footnotes)
    316,500

  • Common Stock

    (indirect: See footnotes)
    466,128

  • Common Stock

    (indirect: See footnotes)
    63,180
BLUMBERG CAPITAL ADVISORS LLC
10% Owner
Transactions
  • Purchase

    Common Stock

    2005-12-27$0.75/sh+18,000$13,500→ 1,782,672 total(indirect: See footnotes)
Holdings

  • Common Stock

    (indirect: See footnotes)
    316,500

  • Common Stock

    (indirect: See footnotes)
    466,128

  • Common Stock

    (indirect: See footnotes)
    63,180
BLUMBERG LAURENCE J
10% Owner
Transactions
  • Purchase

    Common Stock

    2005-12-27$0.75/sh+18,000$13,500→ 1,782,672 total(indirect: See footnotes)
Holdings

  • Common Stock

    (indirect: See footnotes)
    316,500

  • Common Stock

    (indirect: See footnotes)
    466,128

  • Common Stock

    (indirect: See footnotes)
    63,180
BLUMBERG LIFE SCIENCES FUND LTD
10% Owner
Transactions
  • Purchase

    Common Stock

    2005-12-27$0.75/sh+18,000$13,500→ 1,782,672 total(indirect: See footnotes)
Holdings

  • Common Stock

    (indirect: See footnotes)
    316,500

  • Common Stock

    (indirect: See footnotes)
    63,180

  • Common Stock

    (indirect: See footnotes)
    466,128
BLUMBERG LOUIS
10% Owner
Transactions
  • Purchase

    Common Stock

    2005-12-27$0.75/sh+18,000$13,500→ 1,782,672 total(indirect: See footnotes)
Holdings

  • Common Stock

    (indirect: See footnotes)
    63,180

  • Common Stock

    (indirect: See footnotes)
    316,500

  • Common Stock

    (indirect: See footnotes)
    466,128
Footnotes (5)
  • [F1]Each of the Reporting Persons and the joint filers (individually, each a "Reporting Person" and collectively, the "Reporting Persons") disclaims beneficial ownership of the reported securities except to the extent of his or its pecuniary interest therein. The Reporting Persons may be deemed to be a "group" for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, and are reporting beneficial ownership of the securities held by each of the other Reporting Persons as if beneficially owned by each Reporting Person. The information contained in Table I and Table II of this Form 4 replaces, in its entirety, the Form 4 filed 12/17/2004.
  • [F2]These securities are held by AFB Fund, LLC ("AFB"), a New Jersey limited liability company of which Louis Blumberg is the manager and Laurence J. Blumberg is a member. By virtue of Louis Blumberg's position as the manager of AFB, he may be deemed to beneficially own the securities held by AFB. By virtue of Laurence J. Blumberg's position as a member of AFB, he may be deemed to beneficially own the securities held by AFB.
  • [F3]These securities are held by Laurence J. Blumberg.
  • [F4]These securities are held by Blumberg Life Sciences Fund, L.P. ("BLSF"). Blumberg Capital Adivsors, L.L.C. ("BCA"), the general partner of BLSF, may be deemed to beneficially own these securities by virtue of its position as general partner of BLSF. Blumberg Capital Management, L.L.C. ("BCM") has been delegated investment advisory responsibilities by BCA. BCM may be deemed to beneficially own the securities held by BLSF by virtue of BCM's position as investment manager of BLSF. Laurence J. Blumberg is the managing member of BCM and BCA. By virtue of his position as the managing member of BCM and BCA, Laurence J. Blumberg may be deemed to beneficially own the securities held by BLSF.
  • [F5]These securities are held by Blumberg Life Sciences Fund, Ltd. ("BLS"). BCM is the investment manager of BLS and may be deemed to beneficially own the securities held by BLS by virtue of its position as investment manager of BLS. By virtue of his position as the managing member of BCM, Laurence J. Blumberg may be deemed to beneficially own the securities held by BLS.

Documents

1 file

Issuer

CAMBRIDGE HEART INC

CIK 0000913443

→
Entity typeother

Related Parties

1
  • filerCIK 0001241459

Filing Metadata

Form type
4/A
Filed
Jan 2, 7:00 PM ET
Accepted
Jan 3, 5:13 PM ET
Size
18.5 KB
View on SEC.gov